OR14,84 Twelve months safety and efficacy of LB03002, a new prolonged release formulation of rhGH, as compared to daily rhGH therapy in treatment-naïve children with growth failure due to insufficient secretion of endogenous growth hormone (GHD)

✍ Scribed by P.H. Saenger; V. Khadilkar; K.A. Radjuk; E. Bolshova; R. Khadgawat; M. El Kholy; V. Peterkova; M. Desai; V. Mericq; C. Savoy; H.-J. Ji; Z. Zadik; J. Kratzsch; M. Bidlingmaier

• Book ID: 117734866
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 132 KB
• Volume: 20
• Category: Article
• ISSN: 1096-6374
• DOI: 10.1016/s1096-6374(10)70100-3